📰 Afmd News
Page 4 - Afmd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Afmd. Real-time updates on events, politics, business and more.
May 22, 2023
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Get Rating) in a research note released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the company. Wells Fargo & Company reiterated an overweight rating and set a $7.00 price target on shares of […]
May 20, 2023
Research analysts at StockNews.com started coverage on shares of Affimed (NASDAQ:AFMD – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Several other analysts have also recently commented on AFMD. Stifel Nicolaus reduced their price target on Affimed from $2.00 to $1.00 […]
May 17, 2023
Affimed (NASDAQ:AFMD – Get Rating) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 23rd. Analysts expect Affimed to post earnings of ($0.22) per share for the quarter. Affimed (NASDAQ:AFMD – Get Rating) last posted its quarterly earnings results on Thursday, March 23rd. The biopharmaceutical company reported ($0.22) earnings […]
May 4, 2023
Shares of Affimed (NASDAQ:AFMD – Get Rating) have been assigned an average rating of “Moderate Buy” from the eight analysts that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the […]
May 3, 2023
Affimed (NASDAQ:AFMD – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 5,830,000 shares, a growth of 9.2% from the March 31st total of 5,340,000 shares. Based on an average trading volume of 1,010,000 shares, the days-to-cover ratio […]
May 2, 2023
Shares of Affimed (NASDAQ:AFMD – Get Rating) have earned a consensus rating of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. The […]
April 17, 2023
Affimed (NASDAQ:AFMD – Get Rating) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 5,340,000 shares, a growth of 36.2% from the March 15th total of 3,920,000 shares. Based on an average trading volume of 1,170,000 shares, the short-interest ratio is currently 4.6 […]
April 9, 2023
Affimed (NASDAQ:AFMD – Get Rating) has been given an average rating of “Moderate Buy” by the eight ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. The […]
April 9, 2023
Affimed (NASDAQ:AFMD – Get Rating) has been given an average rating of “Moderate Buy” by the eight analysts that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating on the company. The […]
March 30, 2023
Several brokerages have updated their recommendations and price targets on shares of Affimed (NASDAQ: AFMD) in the last few weeks: 3/27/2023 – Affimed had its “overweight” rating reaffirmed by analysts at Wells Fargo & Company. They now have a $7.00 price target on the stock. 3/24/2023 – Affimed was downgraded by analysts at StockNews.com from […]